Dr Usha Y Nayak
Vice Principal and Professor
Date of Joining : 01.04.2010
Department of Pharmaceutics
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
- Teaching BPharm, DPharm, MPharm students
- Serving as member of 'Publicity and Website Council', and? 'Disciplinary Council' 必威体育betway888 College of Pharmaceutical Sciences, 必威体育betway888
- Guiding?MPharm?and ?PhD?students
- Guides PG student projects of MCODS (必威体育betway888 College of Dental Sciences), 必威体育betway888
- Principal Investigator for the research projects funded by government and private funding agencies (ICMR-New Delhi, AICTE-New Delhi; DBT-New Delhi; VGST-Karnataka, India; LifeScient- USA; SERB-New Delhi)?
- Serving as mentor for MAHE Student 必威体育betway888 Forum
- Reviewer and coordinator for MAHE PhD protocol approval commitee
Usha Y Nayak is a Professor of Department of Pharmaceutics and Vice Principal of MCOPS.
She is?
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Pharmaceutics-I (Theory) | BPharm Sem-I |
| Pharmaceutics-I (Practical) | BPharm Sem-I |
| Industrial Pharmacy - II | BPharm Sem - VII |
| Practice School | BPharm SEM - VII |
| Industrial Pharmacy Practical I | MPharm Industrial Pharmacy Sem-I |
| Pharmaceutical Production Technology | MPharm Industrial Pharmacy Sem II |
| Industrial Pharmacy Practical II | MPharm Industrial Pharmacy Sem-II |
| Computer Aided Drug Delivery Systems | MPharm Pharmaceutics Sem-II |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| PhD | Pharmaceutics, Pharmaceutical Sciences | 必威体育betway888 Academy of Higher Education | 2010 |
| MPharm | Pharmaceutics | 必威体育betway888 Academy of Higher Education, 必威体育betway888 | 2006 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| MCOPS, 必威体育betway888 | Professor | Teaching, 必威体育betway888 and Documentation | June 2023 onwards |
| MCOPS, 必威体育betway888 | Additional Professor | Teaching, 必威体育betway888 and Documentation | Feb 2022 to May 2023 |
| MCOPS, 必威体育betway888 | Associate Professor | Teaching, 必威体育betway888 and Documentation | April 2015 to Jan 2022 |
| MCOPS, 必威体育betway888 | Assistant Professor - Senior Scale | Teaching, 必威体育betway888 and Documentation | 2013 to 2015 |
| MCOPS, 必威体育betway888 | Assistant Professor | Teaching, 必威体育betway888 and Documentation | 2013 |
| MCOPS, 必威体育betway888 | Lecturer | Teaching, 必威体育betway888 and Documentation | 2010 to 2013 |
Development and evaluation of lipid based delivery systems for lymphatic targeting
Funded by DBT under Bio-CARe scheme [No.BT/Bio-CARe/03/9943/2013-14], New Delhi - Completed
Development of liposomes for brain targeting of antipsychotic drug
Funded by AICTE under CAYT scheme [11-34/RIFD/CAYT/POL-1/2014-15 ], New Delhi - Completed
Development of Implantable dosage forms
Funded by Life Scient Inc, USA - Ongoing
Formulation optimization of novel anti-HIV Nanosuspension formulation
Funded by Vision Group on Science and Technology (VGST), Bengaluru, Karnataka, India [KSTePS/VGST-RGS/F/GRD No.706/2017-18] - Ongoing
Development of transdermal formulations for breast cancer treatment
Funded by Science and Engineering 必威体育betway888 Board( SERB), New Delhi, India [EMR/2016/007006] - Ongoing
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Novel Drug Delivery and Bioavailability Enhancement
Area of Expertise
Nanopharmaceuticals - Nanocomposites, Nanocubogels, liposomes, solid lipid nanoparticles, Nano structured lipid carriers, Mesoporous silica nanoparticles; Bioavailability Enhancement - Nanoemulsions, Nanocrystals, Nanosuspension; Oral controlled delivery (Chronotherapy); PLGA and PLA Microspheres
Area of 必威体育betway888
Controlled Drug Delivery
Professional Affiliations & Contributions
Funded Projects:
?
- Principal Investigator for the research projects funded by government and private funding agencies (AICTE-New Delhi; DBT-New Delhi; VGST-Karnataka, India; LifeScient- USA; SERB-New Delhi)?
- Development of transdermal formulations for cancer treatment, Science and Engineering 必威体育betway888 Board (SERB), New Delhi, India [EMR/2016/007006] - Ongoing
- Formulation optimization of novel anti-HIV Nanosuspension formulation, Vision Group on Science and Technology (VGST), Bengaluru, Karnataka, India [KSTePS/VGST-RGS/F/GRD No.706/2017-18] - Ongoing
- Development of Implantable dosage forms, Life Scient Inc, USA - Ongoing
- Development of liposomes for brain targeting of antipsychotic drug, Career Award for young teachers Career Award for Young scientist (CAYT), All India Council for Technical Education, New Delhi, India - Completed
- Development and evaluation of lipid based delivery systems for lymphatic targeting, Department of Biotechnology, New Delhi, India -Completed
Collaborations:
?
- National collaboration is with Prof. Ashok M Raichur, Dept. of Materials Engineering, Indian Institute of Science, Bangalore, India and Prof. Purnima D Amin, Institute of Chemical Technology, Mumbai
- 必威体育betway888 collaboration with Prof. Sanjay Garg, University of 必威体育betway888 Australia, Adelaide for the MPharm and PhD research.
?
Achievements:
?
- Received Travel Grants from ICMR, New Delhi; Centre for 必威体育betway888 Co-operation in Science CICS, Chennai and DBT, New Delhi for attending World Conference on Pharmacology at Brisbane, Australia held from 20th to 22nd July 2015.
- Awarded “First Prize in poster presentation” entitled Chronotherapeutic Drug Delivery in the Management of Hypertension, 3rd 必威体育betway888 Non Communicable Diseases (NCD) 必威体育betway888 Meet-必威体育betway888 Chapter-2015, 必威体育betway888 University, 必威体育betway888. 10-11 January, 2015.
- Awarded “First Prize in poster presentation” entitled, Nanotechnology in Anti-HIV Therapy, A poster competition for “AIDS FREE INDIA-HYPE or HOPE” event organized by community development committee, 必威体育betway888 University Association of Pharmacy Students in Collaboration with ISPOR, MUSC, held on 30th November, 2014 (World Aids Day).
- Awarded “First Prize in poster presentation” for the paper entitled ‘Development and evaluation of Risperidone liposomes for brain targeting’ in the TEQIP II and DBT sponsored 必威体育betway888 Conference on the Innovations and Future 必威体育betway888 Dimensions on Nanobio Pharmaceutical Technology held at the Department of Pharmaceutical Technology (Centre for Excellance in Nanobio Translational 必威体育betway888), Anna University, BIT Campus, Tiruchirapalli, Tamilnadu, India during 7-8th October, 2014.
- Awarded “Second Prize in poster presentation” at 必威体育betway888 Humboldt Kolleg on ‘Bench to Bedside Translational 必威体育betway888’ Potential Benefits of Interdisciplinary Collaboration, 15-17 Nov 2013, Kasturba Medical College, 必威体育betway888 for poster presentation entitled ‘Gastro Retentive Pulsatile Release Lercanidipine HCl Formulations: Development, evaluation, in Vivo Buoyancy and Pharmacokinetic Study”
- Awarded ‘Annual Best 必威体育betway888 Paper Award 2010 in Pharmaceutical Sciences of 必威体育betway888 University’ instituted by Dr. N. Udupa, Principal, MCOPS, 必威体育betway888.
- Awarded Dr. T. M. A. Pai Gold Medal for the Best Out – going B. Pharm student of 必威体育betway888 College of Pharmaceutical Sciences, 必威体育betway888 for the year 2002-03.
Current memberships in professional societies and chapters:
- Registered Pharmacist, Karnataka State Pharmacy Council, Bangalore.
- Life member of Association of Pharmacy Teachers of India (APTI).
- Life member of Association of Community Pharmacist of India.
- Life member of Association of Hospital Pharmacist of India.
Full publication list can be viewed at
https://manipal.pure.elsevier.com/en/persons/usha-y-nayak
https://eprints.manipal.edu/view/creators/Nayak=3AUsha_Y=3A=3A.html
Formulation, characterization and in vivo evaluation of self-nanoemulsifying drug delivery system for oral delivery of valsartan
Usha Y Nayak Maulick Chopra Koteshwara KB Aravind Kumar G M Sreenivasa Reddy
Current Nanoscience, 10, 263-270 (2014).
Nanomedicine of anastrazole for breast cnacer: Physicochemical evaluation, in vitro cytoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model
Gopal V Shavi Usha Y Nayak Naseer M Udupa N Sreenivasa Reddy M
Life Sciences. 141: 143-155 (2015).
Preparation, Characterization and Pharmacokinetic Study of Nelfinavir Nanocrystals for Oral Bioavailability Enhancement
Usha Y Nayak Naga Naresh D Musmade P Mutalik S Nayak Y
Current Nanoscience, 11, 379-387 (2015).
PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation
Gopal Venkatesh Shavi Meka Sreenivasa Reddy Ramesh Raghavendra Averineni Ranjith Kumar Praful Balavant Deshpande Nayanabhirama Udupa
J Liposome Res. 2016, 26(1): 28–46.
Timed-release compression-coated tablet composition for chronotherapy of hypertension
Granted an Indian Patent (Patent No.:286353)
Trademarks Registration 'Nanocubogel'
Registered by Trademarks Registry, Govt. of India dated 03 Jult 2023
Formulation and Evaluation of Immediate Release Tablets of Nsaids
Kontham Sainath Reddy
PG Project (2014)
Formulation Development and Evaluation of Risperidone Liposomes for Brain Targeting Through Intranasal Route
Mohan Singh
PG Project (2014)
Development and Evaluation of Solid Lipid Nanoparticles of Ritonavir For Lymphatic Targeting Through Oral Route
Swapnil Kumar
PG Project (2015)
Formulation and Evaluation of Chronomodulated Bilayer Tablets of Montelukast Sodium and Fexofenadine HCl
Anuj Narang
PG Project (2015)
Product Development of Azithromycin for Injection by Lyophilization Technique
Aakaram Mahesh Kumar
PG Project (2015)
Formulation And Evaluation of Nanoparticles To Treat Breast Cancer
Bisakha Roy
PG project (2016)
Formulation Development Of Ritonavir Proliposomes For Lymphatic Targeting
Vasif Ahammed S K
PG project (2016)
Development of MSNs for colon cancer
Reema Narayan
PhD project (2016)